Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.37 |
| ▸ | GRIA1 | P42261 | 3/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | GMNN | O75496 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dimethylamine SCHEMBL28812089 | 1.00 | SLC22A6 (0.37) | SLC22A6GRIA1TDP1TSHRALDH1A1 | |
| Dimethylamine SCHEMBL28954501 | 0.97 | SLC22A6 (0.36) | SLC22A6GRIA1TDP1TSHRALDH1A1 | |
| SCHEMBL20898290 | 0.92 | — | — | |
| SCHEMBL549356 | 0.92 | — | — | |
| SCHEMBL9392015 | 0.89 | — | — | |
| SCHEMBL4299562 | 0.89 | — | — | |
| SCHEMBL19809590 | 0.89 | — | — | |
| SCHEMBL1138591 | 0.89 | — | — | |
| Water SCHEMBL19282561 | 0.89 | SLC22A6 (0.40) | SLC22A6GRIA1TDP1TSHRALDH1A1 | |
| SCHEMBL1138621 | 0.89 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0392865-B1 | Extraction procedure | UNILEVER PLC (GB) | 1994-07-13 | — | — | EP | claimed |
| CN-111004835-B | Stable formulations for luminescent detection of luciferases and nucleoside phosphates | 普洛麦格公司 | 2023-12-29 | — | — | CN | disclosed |
| CN-102532321-B | Novel antigen-binding polypeptides and its purposes | AMBRX公司 | 2018-10-12 | — | — | CN | disclosed |
| CN-105039495-B | A kind of 3 α HSD reagents and its preparation method and application | 中生北控生物科技股份有限公司 | 2017-12-15 | — | — | CN | disclosed |
| CN-106443006-A | Methods and compositions comprising non-natural amino acids | AMBRX公司 | 2017-02-22 | — | — | CN | disclosed |
| CN-102603895-B | Novel antigen-binding polypeptides and its purposes | AMBRX公司 | 2016-09-28 | — | — | CN | disclosed |
| CN-103965300-A | Biosynthetic Polypeptide Fusion Inhibitors | AMBRX INC | 2014-08-06 | — | — | CN | disclosed |
| CN-101489571-B | Biosynthetic polypeptide fusion inhibitors | AMBRX INC | 2014-06-18 | — | — | CN | disclosed |
| CN-102603895-A | Novel antigen-binding polypeptides and their uses | AMBRX INC | 2012-07-25 | — | — | CN | disclosed |
| CN-102532321-A | Novel antigen-binding polypeptides and their uses | AMBRX INC | 2012-07-04 | — | — | CN | disclosed |
| CN-1968712-B | Novel antigen binding polypeptides and uses thereof | AMBRX INC | 2012-05-16 | — | — | CN | disclosed |
| CN-1914223-B | Modified human four-helix bundle polypeptides and uses thereof | AMBRX INC | 2012-02-29 | — | — | CN | disclosed |
| CN-102264697-A | Biosynthetically generated pyrroline-carboxy-lysine and site-specific protein modification by chemical derivatization of pyrroline-carboxy-lysine and pyrrolysine residues | — | 2011-11-30 | — | — | CN | disclosed |
| CN-101489571-A | Biosynthetic polypeptide fusion inhibitors | AMBRX INC (US) | 2009-07-22 | — | — | CN | disclosed |
| CN-101454461-A | Methods and compositions comprising unnatural amino acids | AMBRX INC (US) | 2009-06-10 | — | — | CN | disclosed |
| CN-101001866-A | Modified human interferon polypeptides and their uses | AMBRX INC (US) | 2007-07-18 | — | — | CN | disclosed |
| CN-1968712-A | Novel antigen binding polypeptides and uses thereof | AMBRX INC (US) | 2007-05-23 | — | — | CN | disclosed |
| CN-1942589-A | Modified human growth hormone polypeptides and uses thereof | AMBRX INC (US) | 2007-04-04 | — | — | CN | disclosed |
| CN-1914223-A | Modified human four-helix bundle polypeptides and uses thereof | AMBRX INC (US) | 2007-02-14 | — | — | CN | disclosed |
| CN-1568370-A | treatment of central nervous system disorders with D-amino acid oxidase and D-aspartate oxidase antagonists | GENSET SA (FR) | 2005-01-19 | — | — | CN | disclosed |